Cerebrospinal hepatocyte growth factor levels correlate negatively with disease activity in multiple sclerosis
Authors:
- Esther JunEJEsther Jun
- Hana ConlonHCHana Conlon
- Saud Ahmed SadiqSSSaud Ahmed Sadiq
- 1 October 2012
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 251 (1-2) , 80-86
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25 + Foxp3 + regulatory T cellsProceedings of the National Academy of Sciences, 2010
- Gene expression profiling in multiple sclerosis: A disease of the central nervous system, but with relapses triggered in the periphery?Neurobiology of Disease, 2010
- Multiple sclerosisThe Lancet, 2008
- Essential Contribution of Monocyte Chemoattractant Protein-1/C-C Chemokine Ligand-2 to Resolution and Repair Processes in Acute Bacterial PneumoniaThe Journal of Immunology, 2004
- Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinaseTrends in Cell Biology, 1998
- Cytokine gene expression in cells derived from CSF of multiple sclerosis patientsJournal of Neuroimmunology, 1998
- Expression of HGF and cMet in the developing and adult brainDevelopmental Brain Research, 1997
- Hepatocyte Growth Factor/Scatter Factor Is an Axonal Chemoattractant and a Neurotrophic Factor for Spinal Motor NeuronsNeuron, 1996
- Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb budNature, 1995
- Hepatocyte growth factor and macrophage inflammatory protein 1 beta: structurally distinct cytokines that induce rapid cytoskeletal changes and subset-preferential migration in T cells.Proceedings of the National Academy of Sciences, 1994